Table 2.
Baseline characteristics according to single-vessel or multi-vessel CAD
| Total (n = 2792) |
Single-vessel CAD (n = 633) |
Multi-vessel CAD (n = 2159) |
P-value | |
|---|---|---|---|---|
| Age (years) | 66 ± 10 | 65 ± 10 | 66 ± 10 | < 0.01 |
| Male (n,%) | 1927 (69.02%) | 359 (56.71%) | 1568 (72.62%) | < 0.01 |
| SBP (mmHg) | 136 ± 18 | 136 ± 18 | 135 ± 18 | 0.58 |
| DBP (mmHg) | 77 ± 12 | 77 ± 11 | 77 ± 12 | 0.56 |
| FPG (mmol/l) | 6.36 ± 2.22 | 5.92 ± 1.68 | 6.49 ± 2.34 | < 0.01 |
| BMI (Kg/m2) | 25.71 ± 3.34 | 25.79 ± 3.38 | 25.68 ± 3.32 | < 0.01 |
| HDL-C (mg/dL) | 1.04 ± 0.25 | 1.10 ± 0.27 | 1.03 ± 0.25 | 0.92 |
| LDL-C (mg/dL) | 2.12 ± 0.80 | 2.12 ± 0.78 | 2.12 ± 0.81 | 0.92 |
| TC (mg/dL) | 3.72 ± 0.93 | 3.77 ± 0.90 | 3.71 ± 0.94 | 0.17 |
| HbA1c (%) | 6.59 ± 1.23 | 6.33 ± 1.03 | 6.67 ± 1.27 | < 0.01 |
| eGFR | 85.97 ± 17.08 | 88.88 ± 14.02 | 85.11 ± 17.79 | < 0.01 |
| Smoking (n, %) | 1299 (46.53%) | 250 (39.49%) | 1049 (48.59%) | < 0.01 |
| Drinking (n, %) | 1771 (63.43%) | 394 (62.24%) | 1377 (63.78%) | 0.48 |
| Hypertension (n, %) | 1949 (69.81%) | 412 (65.09%) | 1537 (71.19%) | < 0.01 |
| Glucose metabolism state | ||||
| NGR (n, %) | 530 (18.98%) | 157 (24.80%) | 373 (17.28%) | < 0.01 |
| Pre-DM (n, %) | 1038 (37.8%) | 257 (40.60%) | 781 (36.17%) | < 0.01 |
| DM (n, %) | 1224 (43.84%) | 219 (34.60%) | 1005 (46.55%) | < 0.01 |
| Medications | ||||
| Antiplatelets (n, %) | 2643 (94.66%) | 595 (94.00%) | 2048 (94.86%) | 0.40 |
| Antihypertensive drugs (n, %) | 2317 (82.99%) | 491 (77.57%) | 1826 (84.58%) | < 0.01 |
| Antilipidemic drugs (n, %) | 2629 (94.16%) | 590 (93.21%) | 2039 (94.44%) | 0.25 |
SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, BMI body mass index, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TC total cholesterol, HbA1c glycated hemoglobin A1c, eGFR estimated glomerular filtration rate, NGR normoglycemia, Pre-DM pre-diabetes mellitus, DM diabetes mellitus, CAD coronary artery disease